A Common Path to Unconsciousness

Analyses of brain activity patterns show that different drugs induce anesthesia via a common neural mechanism.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

KetamineWIKIMEDIA, PSYCHONAUTDiverse anesthetic drugs, each with distinct molecular targets, disrupt communication between the front and rear of the brain, according to a new study published today (May 22) in Anesthesiology. The findings provide the strongest evidence yet that inhibition of frontal-parietal connectivity may be the common mechanism by which all anesthetics induce loss of consciousness.

“If the study’s findings are confirmed by subsequent work, the paper will achieve landmark status,” wrote Jamie Sleigh of the University of Auckland, who was not involved in the study, in an accompanying commentary. “[It] not only sheds light on the phenomenon of general anesthesia, but also how it is necessary for certain regions of the brain to communicate accurately with one another for consciousness to emerge.”

Researchers already knew that the commonly used anesthetics sevoflurane and propofol break down this particular route of brain communication. But it was not clear if ketamine, which acts on different molecular targets, works in the same way. To find out, a team led by George Mashour of the University of Michigan, Ann Arbor, analyzed electroencephalogram (EEG) recordings from ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Dan Cossins

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide